[{"Assets_0_Q1_USD":69181000000.0,"CIK":"818686","CommonStockSharesConverted_0_Q1_shares":1124000000.0,"Country":"Israel","EarningsPerShareBasic_1_Q1_USD":1.04,"EarningsPerShareDiluted_1_Q1_USD":1.03,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"11303387401.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":1496000000.0,"NetIncomeLossConverted_1_Q1_USD":1120000000.0,"OfficialName":"Teva Pharmaceutical Industries Limited American Depositary Shares","RevenuesConverted_1_Q1_USD":5065000000.0,"SP500":"nan","Sector":"Health Care","StockholdersEquityConverted_0_Q1_USD":20102000000.0,"StockholdersEquity_0_Q1_USD":18621000000.0,"Ticker":"TEVA","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":1017000000.0,"filed":"20180503","footnote":"nan","form":"10-Q","fp":"Q1","fy":"2018.0","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","period":"20180331","qtrs":"0","uom":"USD"}]